RKVTFRAKOVINA THERAPEUTICS INC

About RAKOVINA THERAPEUTICS INC (RKVTF)

RAKOVINA THERAPEUTICS INC (RKVTF) is a Biotechnology company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the Pink tier.

Rakovina Therapeutics Inc. engages in the research and development of new cancer treatments based on novel series of small-molecule DNA-damage response inhibitors (DDRi). Its preclinical product pipeline include kt-2000, a next generation oral targeted small molecule PARP inhibitors; kt-3000, a bi-functional small-molecule drug candidate; and kt-4000, a DNA-damaging DDR inhibitors.

RKVTF key facts

Ticker symbol

RKVTF

Market tier

Pink

Sector

Healthcare

Industry

Biotechnology

Headquarters

Vancouver, BC, Canada

Estimated market cap

$5.33M (as of Apr 11, 2025)

Shares outstanding

140,792,575

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Biotechnology stocks · Healthcare sector · Pink stocks · OTC stocks starting with R